D-1152-2014 Class III Terminated
FDA drug recall D-1152-2014 was initiated by Fougera Pharmaceuticals Inc. on Jan 29, 2014 and is designated Class III. Reason for recall: Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%. The recall status is terminated (terminated Dec 8, 2015). Affected quantity: 493,192 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 19, 2014
- Initiation Date
- Jan 29, 2014
- Termination Date
- Dec 8, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 493,192 tubes
Product description
Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera & Co., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0004-80, UPC 3 0168-0004-80 8.
Reason for recall
Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.
Distribution pattern
Nationwide.
Code information
Lot #: 485P, 486P, 487P, 488P, Exp 06/15; 638P, 639P, 640P, Exp 07/15; 753P, 754P, 755P, Exp 08/15; 898P, 756P, 757P, 758P, 899P, 900P, 901P, 902P, Exp 09/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1152-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026